Poonam Alaigh, MD, MSHCPM, FACPResearch Professor, Director of Innovation PERU, Pharmacy and Therapeutics
Dr. Poonam Alaigh, a Research Professor at the University of Pittsburgh, is the President and CEO of Alaigh Care Associates, a leading national healthcare consulting company committed to creating innovative, sustainable, system-based transformation. She was previously the Executive Vice President of Corporate Development for Remedy Partners leading collaborative partnerships, key investment opportunities and innovative solutions facilitate the adoption of value-based payment models across the country.
Prior to joining Remedy, she was the Acting Under Secretary for Health at the Department of Veterans Affairs and directed a health care system with an annual budget of approximately $70 Billion, overseeing the delivery of care to more than 9 million enrolled Veterans. VA, the nation's largest health care system, operates more than 1,200 sites of care, including hospitals; community-based outpatient clinics; nursing homes; domiciliaries; and 300 Vet Centers. VHA is the nation's largest provider of graduate medical education and a major contributor to medical and scientific research. More than 73,000 active volunteers, 123,000 health professions trainees, and 306,000 full time health care professionals and support staff are an integral part of the VHA community. She previously served as the Senior Advisor to the Under Secretary for Health, at the US Veterans Health Administration (VHA) and was the executive sponsor of the MyVA Access initiative. Through her leadership and guidance, she was a core member of the team strategizing and executing the largest transformation at the VA to meet the top priority of the USH that improved access to care for all veterans. This resulted in same day services for urgent primary and mental health care needs of our Veterans.
Dr. Alaigh has a multifaceted background in health care administration and delivery, including clinical practice, hospital practice, hospital administration, managed care, pharmaceutical medicine, and healthcare policy. She was the co-founder of one of the first and largest ACOs in the country, the Atlantic Accountable Care Organization in NJ with 350K members, 100K Medicare beneficiaries, 5 hospitals and 2500 physicians. In her role as Commissioner of the Department of Health and Senior Services of New Jersey she had oversight of a department with 1700 employees and a budget of $3.7B that was responsible for health care policy, public health, senior care and quality with regulatory oversight responsibility of all the healthcare institutions in NJ. As the Executive Medical Director at Horizon Blue Cross Blue Shield of New Jersey, she was responsible for operational oversight of all the major clinical areas to ensure the delivery of quality, cost effective healthcare for its members. She has served as National Medical Director for GlaxoSmithKline where she was working with health plans on national issues, including better use of health care technology, the reduction of disparities and healthcare access to the under and uninsured population.
She is a board-certified internist with a specialty in vascular diseases and a Master of Science in Health Care Policy and Management at the State University of New York at Stony Brook, NY. She is a certified black belt in six-sigma business management strategy. She is a recognized national healthcare leader and has authored a number of articles and publications.